ARSA (Search Result) Help

Search Result

Facet

Division

now loading

    Organism_facet

    now loading

      List of Entries

      1 - entries / Number of founds: 498890  
        PrimaryAccessionNumber Definition SequenceLength MolecularType Organism
      OF298622 KR 1020210131855-A/4: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer. 19 RNA synthetic construct
      OF298627 KR 1020210131855-A/9: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer. 19 RNA synthetic construct
      OF298620 KR 1020210131855-A/2: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer. 19 RNA synthetic construct
      OF298625 KR 1020210131855-A/7: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer. 19 RNA synthetic construct
      OF298630 KR 1020210131855-A/12: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer. 23 DNA synthetic construct
      OF298621 KR 1020210131855-A/3: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer. 18 RNA synthetic construct
      OF298626 KR 1020210131855-A/8: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer. 19 RNA synthetic construct
      OF298623 KR 1020210131855-A/5: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer. 19 RNA synthetic construct
      OF298628 KR 1020210131855-A/10: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer. 19 RNA synthetic construct
      OF756628 KR 1020210131855-A/17: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer. 415 PRT synthetic construct
      OF756630 KR 1020210131855-A/21: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer. 3972 PRT synthetic construct
      OF298619 KR 1020210131855-A/1: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer. 19 RNA synthetic construct
      OF298624 KR 1020210131855-A/6: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer. 20 RNA synthetic construct
      OF298629 KR 1020210131855-A/11: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer. 23 DNA synthetic construct
      OF756629 KR 1020210131855-A/19: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer. 801 PRT synthetic construct
      DI181556 KR 1020090098677-A/6: Method for Detecting Lung Cancer Using Lung Cancer Specific Methylated Marker Gene. 24 DNA artificial sequences
      DI181564 KR 1020090098677-A/14: Method for Detecting Lung Cancer Using Lung Cancer Specific Methylated Marker Gene. 26 DNA artificial sequences
      HV444571 JP 2011515081-A/5: Method for detecting lung cancer using lung cancer-specific methylation marker gene. 30 DNA synthetic construct
      HV444579 JP 2011515081-A/13: Method for detecting lung cancer using lung cancer-specific methylation marker gene. 22 DNA synthetic construct
      HV444587 JP 2011515081-A/21: Method for detecting lung cancer using lung cancer-specific methylation marker gene. 19 DNA synthetic construct
      HZ489210 JP 2016015948-A/8: METHODFOR OBTAINING INFORMATION ON LUNG CANCER, AND MARKERS AND KIT FOR OBTAINING INFORMATION ON LUNG CANCER. 22 DNA synthetic construct
      DI896029 KR 1020160051475-A/2: Composition and kit for diagnosing lung cancer and method for diagnosis of lung cancer using the same. 183 PRT synthetic construct
      DI896030 KR 1020160051475-A/4: Composition and kit for diagnosing lung cancer and method for diagnosis of lung cancer using the same. 138 PRT synthetic construct
      DI896031 KR 1020160051475-A/6: Composition and kit for diagnosing lung cancer and method for diagnosis of lung cancer using the same. 226 PRT synthetic construct
      DI896032 KR 1020160051475-A/8: Composition and kit for diagnosing lung cancer and method for diagnosis of lung cancer using the same. 2272 PRT synthetic construct
      DI181561 KR 1020090098677-A/11: Method for Detecting Lung Cancer Using Lung Cancer Specific Methylated Marker Gene. 21 DNA artificial sequences
      DI181569 KR 1020090098677-A/19: Method for Detecting Lung Cancer Using Lung Cancer Specific Methylated Marker Gene. 20 DNA artificial sequences
      HZ489205 JP 2016015948-A/3: METHODFOR OBTAINING INFORMATION ON LUNG CANCER, AND MARKERS AND KIT FOR OBTAINING INFORMATION ON LUNG CANCER. 118 DNA synthetic construct
      HV444575 JP 2011515081-A/9: Method for detecting lung cancer using lung cancer-specific methylation marker gene. 28 DNA synthetic construct
      HV444583 JP 2011515081-A/17: Method for detecting lung cancer using lung cancer-specific methylation marker gene. 22 DNA synthetic construct
      Now loading
      PAGE TOP